Coreg. Buy more. Save more.

Decision Resources (Waltham, MA), one of the world’s leading research and advisory firms for pharmaceutical and healthcare issues, finds that the patent expiries of key therapies, most notably GlaxoSmithKline’s Coreg and Roche’s Dilatrend/Kredex, will cause the chronic heart failure…